meningococcal infections

39
Meningococcal nasopharyngitis Meningococcemia Meningitis Charan Tejasvi ML-510

Upload: tejasvi-charan

Post on 01-Jun-2015

2.146 views

Category:

Documents


6 download

TRANSCRIPT

Page 1: Meningococcal infections

•Meningococcal nasopharyngitis•Meningococcemia•Meningitis

Charan TejasviML-510

Page 2: Meningococcal infections

Neisseria meningitidis (meningococcus)

gm (-) diplococcus usually found within PMN leucocytes

found only in man

Page 3: Meningococcal infections

13 serogroups by surface capsular polysaccharide

A, B, C, W135 and Y- frequent isolates from patients with meningococcal disease

Other groups isolated from carriers

Meningococcal Infections

Page 4: Meningococcal infections

Common in temperate and tropical climates

carriage rates: healthy children 2-5% military personnel (epidemics) 90%

transmitted via contact with respiratory secretions

Meningococcal Infections

Page 5: Meningococcal infections

Disease may occur following exposure to carriers or infected patients within the family, day care and military camps

occurs most frequent:(< 5 yrs old ) peak attack rate : 6-12 months old

2nd peak attack rate: 15-19 y/o of age

Page 6: Meningococcal infections

Meningococci colonize the nasopharynx penetrate mucosal surface transported by leukocytes to blood stream hematogenous dissemination localizes: heart, CNS, skin, mucous and serous membranes adrenals

Page 7: Meningococcal infections

Release of IL and TNF

hypotension multi-organ system failure

Diffusevasculitis

*Complement activation

DIC

H’ge and necrosis in any organ bleeding into adrenals in patients with septicemia and shock

Waterhouse- Friderichsen syndrome

Page 8: Meningococcal infections

Clinic. The incubation period is from 2 to 10 days (usually 4-6 days).

Clinical classification:Localized forms (acute

nasopharyngitis)Generalized forms

(meningococcemia, meningitis)Rare form (endocarditis, arthritis,

pneumonia, iridocyclitis)

Page 9: Meningococcal infections

spectrum range from asx’c colonization to fulminant sepsis

1. Bacteremia without sepsis 2. Meningococcemia (sepsis) without

meningitis

3. Meningitis with or without meningococcemia

Page 10: Meningococcal infections

Manifested a moderate and short-term (1-3 days)

increase in temperature, mild symptoms of intoxication rhinopharyngitis (nasal congestion,

flushing, dryness, swelling of the posterior pharyngeal wall with hyperplasia of lymphoid follicles affected mucosa "dry", sometimes bluish).

Page 11: Meningococcal infections

From acute viral disease meningococcal nasopharyngitis different is that the mucous membrane of the soft and hard palate, and tonsils are not impaired or only slightly hyperaemic, but major changes are located on the back of the throat.

Page 12: Meningococcal infections

Nasopharyngitis preceded meningococcemia at an average of 78% of patients.

Meningococcemia is inherently meningococcal sepsis, which, like other septic conditions, appears febrile fever and severe intoxication syndrome with manifestations of multiple organ pathology.

Page 13: Meningococcal infections

The most important diagnostic symptom is a “RASH”.

after 5-15 hours of onset single or multiple polymorphic

elements ranging in size from 2.1 mm to 5 cm or more in diameter and has a hemorrhagic character.

asymmetrically, mainly on the skin of the thighs and buttocks, at least - on the trunk and face.

Page 14: Meningococcal infections

Eruptions have different colors - red, brown, yellowish-green. In the center of the elements of necrotizing rash. Most often appear large star-shaped form of hemorrhagic lesions with dense infiltrated the base and necrosis in the center.

Page 15: Meningococcal infections

Initially with pharyngitis, fever, myalgias, arthralgias, headache, and GI complaints within hours--> (+) petechial, purpuric (purpura fulminanas)

( slate gray satellite shaped ) or morbilliform lesions with hypotension, DIC, acidosis,

adrenal h’ge, renal/heart failure, coma

Page 16: Meningococcal infections
Page 17: Meningococcal infections
Page 18: Meningococcal infections
Page 19: Meningococcal infections
Page 20: Meningococcal infections
Page 21: Meningococcal infections

If fulminant--> rapidly progressive purpura, relentless shock, adrenal H’ge, extensive

hematogenous dissemination unresponsive

to therapy

if with meningitis, (most common clinical manifestation) indistinguishable from those

2° to other bacteria

Page 22: Meningococcal infections

(+) petechial < 12° prior to admission (+) hypotension absence of meningitis WBC < 10,000/mm3 ESR < 10 mm/hr.

Interpretation: (+) 3 or > features: 90% mortality > 2 features; 9% mortality

Page 23: Meningococcal infections

Rapid progression of petechia to ecchymoses or purpura Wakefulness skin perfusion respiratory distress thrombocytopenia advanced age

Page 24: Meningococcal infections

Seen in children and adults

low grade fever, non toxic appearance, arthralgias, headache , rash,

(+) blood culture

mean duration of illness: 6-8 weeks

Page 25: Meningococcal infections

Waxing and waning sx purulent arthritis acute non suppurative polyarthritis erythema nodosum URI subacute endocarditis

assoc with C5 deficiency

Chronic Meningococcemia

Page 26: Meningococcal infections

1. Maintain a high index of suspicion (fever, petechial rash, abn mental status)

2. Gm stain of petechial scrapings CSF buffy coat of blood; gm (-) diplococci

Page 27: Meningococcal infections
Page 28: Meningococcal infections

3. Culture of blood, CSF, petechial scraping, synovial

fluid, sputum and other body fluids

4. Antigen detection tests (CSF, urine, serum) CIE, latex agglutination, lack adequate sensitivity and specificity

Page 29: Meningococcal infections

Aq Penicillin G 250,000 -300,000 u/k/day IV 6 div doses x 7 days Alternatives : Cefotaxime 200 mg/k/d Ceftriazone 100-150 mg/k/day

If allergic to B-lactams : Chloramphenicol 75-100 mg/kg d

Page 30: Meningococcal infections

ISOLATION: RESPIRATORY isolation until 24° after effective antibiotics

Page 31: Meningococcal infections

Chemoprophylaxis

for all household, school or day care contacts ASAP or within 24° from diagnosis of 1° case

NOT ROUTINELY recommended for medical personnel EXCEPT those with INTIMATE exposure (mouth to mouth resuscitation, intubation, suctioning)

Page 32: Meningococcal infections

Chemoprophylaxis DOC: Rifampicin 10 mg/kg (max 600 mg) q

12° x 2 days

other drugs: Ceftriaxone Ciprofloxacin

meningococcal vaccine can be used with chemoprophylaxis since 2° cases may occur several weeks later

Page 33: Meningococcal infections

Vaccines available monovalent A bivalent A and C quadrivalent A, C, Y, W135

no effective vaccine against serogroup B

not routinely recommended

Page 34: Meningococcal infections

Recommended: 1. children > 2 yrs.

2. In high risk grps.

(+) functional /anatomic asplenia,

(+) terminal complement component defect +

as adjunct to chemoprophylaxis

Page 35: Meningococcal infections

For Meningitis: deafness ataxia Sz blindness paresis of CN 3,4,6,7, hemi or quadriparesis obstructive hydrocephalus

Page 36: Meningococcal infections

Complications

For Meningococcemia: Adrenal H’ge, arthritis, myocarditis, pericarditis, pneumonia, lung abscess, peritonitis, renal infarcts, DIC, peripheral neuropathy

Vasculitis - 2° bacterial infection tissue necrosis gangrene skin loss

Page 37: Meningococcal infections
Page 38: Meningococcal infections
Page 39: Meningococcal infections